Use of FDA approved therapeutics with hNTCP metabolic...

Antiviral Research 2014 / 06 Vol. 106

Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle

Blanchet, Matthieu, Sureau, Camille, Labonté, Patrick
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
106
Language:
english
Journal:
Antiviral Research
DOI:
10.1016/j.antiviral.2014.03.017
Date:
June, 2014
File:
PDF, 423 KB
english, 2014
Conversion to is in progress
Conversion to is failed